Rocket Lab Corporation $RKLB Shares Bought by Van ECK Associates Corp

Van ECK Associates Corp grew its position in Rocket Lab Corporation (NASDAQ:RKLB) by 42.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,777,325 shares of the rocket manufacturer’s stock after buying an additional 527,552 shares during the period. Van ECK Associates Corp’s holdings in Rocket Lab were worth $180,665,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Swedbank AB raised its stake in shares of Rocket Lab by 8.2% in the fourth quarter. Swedbank AB now owns 509,250 shares of the rocket manufacturer’s stock worth $35,525,000 after purchasing an additional 38,770 shares during the last quarter. BlackRock Inc. bought a new stake in Rocket Lab during the second quarter worth $4,124,970,000. Katamaran Capital LLP grew its holdings in Rocket Lab by 86.2% during the first quarter. Katamaran Capital LLP now owns 19,808 shares of the rocket manufacturer’s stock worth $1,272,000 after buying an additional 9,172 shares in the last quarter. Westfield Capital Management Co. LP raised its position in Rocket Lab by 6.3% in the 4th quarter. Westfield Capital Management Co. LP now owns 2,592,443 shares of the rocket manufacturer’s stock valued at $180,849,000 after buying an additional 154,623 shares during the last quarter. Finally, Y.D. More Investments Ltd purchased a new stake in Rocket Lab in the 1st quarter valued at $642,000. Institutional investors and hedge funds own 71.78% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. New Street Research initiated coverage on shares of Rocket Lab in a report on Wednesday, May 13th. They set a “buy” rating and a $150.00 price objective on the stock. Citizens Jmp reissued a “market outperform” rating and set a $130.00 price target on shares of Rocket Lab in a research report on Tuesday, August 11th. Piper Sandler initiated coverage on shares of Rocket Lab in a report on Wednesday, July 15th. They set a “neutral” rating and a $83.00 price target on the stock. Citigroup reaffirmed a “market outperform” rating on shares of Rocket Lab in a research report on Tuesday, July 28th. Finally, KGI Securities upgraded shares of Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 price objective for the company in a research note on Monday, July 27th. Three research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $110.65.

Key Headlines Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Defense and space-systems demand remain important growth drivers. Rocket Lab is benefiting from its selection by Viasat to build spacecraft buses for the U.S. Space Force’s Protected Tactical SATCOM-Global program. Its HASTE hypersonic test platform is also expanding the company’s exposure to Pentagon missions, supporting the view that Rocket Lab is more than an Electron launch provider. Rocket Lab HASTE defense coverage
• Positive Sentiment: Electron execution and analyst revisions offer potential support. Rocket Lab has reached 93 Electron launches, while some analysts have raised earnings estimates. A hammer chart pattern has also prompted bottom-fishing interest after the decline. Rocket Lab bottom-fisher coverage
• Neutral Sentiment: Analysts remain broadly bullish, but the valuation requires strong execution. Rocket Lab carries a reported “Moderate Buy” consensus and an average price target of $110.65, but the company remains unprofitable and trades at a high valuation relative to current earnings. Its elevated beta also leaves the stock vulnerable to sharp swings.
• Negative Sentiment: Neutron timing is the largest operational risk. Reports that the medium-lift Neutron rocket’s first launch could slip into 2027 have weakened a key investment thesis. The delay would postpone a major revenue and valuation catalyst while extending development costs. Rocket Lab Neutron timeline coverage
• Negative Sentiment: Insider selling adds to near-term pressure. Five executives sold approximately $5.5 million of shares, including sizable sales by the CFO and COO. The transactions were made under Rule 10b5-1 plans to cover tax withholding on vested restricted stock units, reducing their significance, though no comparable insider buying was reported. Rocket Lab executive sale coverage
• Negative Sentiment: Profitability remains a concern. Rocket Lab’s latest quarterly revenue exceeded expectations, but its $0.08-per-share loss was wider than forecast. Continued annual losses make the stock particularly sensitive to acquisition uncertainty, Neutron delays, and any slowdown in launch or defense growth.

Insiders Place Their Bets

In other Rocket Lab news, CFO Adam C. Spice sold 9,677 shares of the company’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $673,809.51. Following the sale, the chief financial officer directly owned 1,155,967 shares of the company’s stock, valued at $80,489,982.21. This represents a 0.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Frank Klein sold 35,558 shares of the stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $66.61, for a total transaction of $2,368,518.38. Following the transaction, the insider owned 925,737 shares of the company’s stock, valued at $61,663,341.57. This represents a 3.70% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 3,524,214 shares of company stock worth $309,110,848 in the last ninety days. 8.40% of the stock is owned by corporate insiders.

Rocket Lab Stock Performance

NASDAQ:RKLB opened at $64.39 on Friday. The company has a market capitalization of $38.53 billion, a P/E ratio of -238.47 and a beta of 2.60. The business has a fifty day simple moving average of $77.80 and a two-hundred day simple moving average of $84.98. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98. Rocket Lab Corporation has a 1 year low of $37.57 and a 1 year high of $151.00.

Rocket Lab (NASDAQ:RKLB) last issued its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). The firm had revenue of $234.07 million for the quarter, compared to analysts’ expectations of $231.62 million. Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. On average, analysts expect that Rocket Lab Corporation will post -0.2 earnings per share for the current year.

Rocket Lab Profile

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.